AGM Information • Jun 12, 2017
AGM Information
Open in ViewerOpens in native device viewer
Chassieu, 12th June 2017
The company's shareholders are invited to attend the ordinary and extraordinary annual general meetings which will be held at:
The notice of the meeting, including the agenda and the planned resolutions, was published in the BALO (Bulletin of obligatory legal announcements) of 17th May 2017; the notice convening the meeting was published in the BALO of 7th June 2017.
The documents stipulated by article R.225-83 of the French commercial code are available to shareholders from the moment that the assembly is convened, in line with the applicable regulatory requirements:
AMOEBA develops a biological biocide BIOMEBA capable of eliminating waterborne bacterial risk. This solution is an alternative to chemicals traditionally used in the cooling water treatment sector. In a worldwide market for chemical biocides estimated to be worth EUR 21 bn(1), AMOEBA is today focusing on the cooling tower application estimated to be worth EUR 1.7 bn(2). BIOMEBA has not yet been granted marketing authorization in the USA, Europe and Canada. AMOEBA is taking the required regulatory steps
to obtain marketing authorizations in those territories for the use of BIOMEBA in cooling water systems. Based in Chassieu (Lyon, France), AMOEBA is quoted on compartment C of the Euronext Paris stock exchange and joined the CAC® Small index on 21st September 2015. For more information: www.amoeba-biocide.com.
(1): Sources combined by Amoeba from water treatment agencies, Freedonia, Eurostat and MarketsandMarkets (2): Amoeba data combined from the following sources: DRIRE 2013, Eurostat, ARHIA 2013
Amoéba Nathalie COMBROUSSE Marketing Communication Manager Tel. : +33 (0)4 81 09 18 15 [email protected]
Actifin Ghislaine GASPARETTO Financial communication +33(0)1 5688 1111 [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.